-transparent.png){kind=logo}
Two hundred and fifty patients admitted with acute myocardial infarction were treated with a continuous infusion of magnesium sulfate for 24 h (a total of 46 mmol of elemental magnesium). Only 1 patient had ventricular fibrillation; no patient had sustained ventricular tachycardia requiring cardioversion. Twenty-five patients had short runs of non-sustained ventricular tachycardia and did not need cardioversion. In 6 further patients, the infusion had to be discontinued because of a drop in blood pressure. The in-hospital mortality for the group was 3.4%.
Related Publications
A S Abraham, and
J Balkin, and
D Rosenmann, and
U Eylath, and
M M Zion
August 1986,
International journal of cardiology,
A S Abraham, and
J Balkin, and
D Rosenmann, and
U Eylath, and
M M Zion
November 1995,
Giornale italiano di cardiologia,
A S Abraham, and
J Balkin, and
D Rosenmann, and
U Eylath, and
M M Zion
March 1986,
Lancet (London, England),
A S Abraham, and
J Balkin, and
D Rosenmann, and
U Eylath, and
M M Zion
March 1992,
The Journal of the Association of Physicians of India,
A S Abraham, and
J Balkin, and
D Rosenmann, and
U Eylath, and
M M Zion
February 1986,
Lancet (London, England),
A S Abraham, and
J Balkin, and
D Rosenmann, and
U Eylath, and
M M Zion
April 1991,
The Journal of the Association of Physicians of India,
A S Abraham, and
J Balkin, and
D Rosenmann, and
U Eylath, and
M M Zion
April 2007,
The Cochrane database of systematic reviews,
A S Abraham, and
J Balkin, and
D Rosenmann, and
U Eylath, and
M M Zion
December 1989,
American heart journal,
A S Abraham, and
J Balkin, and
D Rosenmann, and
U Eylath, and
M M Zion
February 1992,
BMJ (Clinical research ed.),
A S Abraham, and
J Balkin, and
D Rosenmann, and
U Eylath, and
M M Zion
February 1994,
The Annals of pharmacotherapy,
